9.20BMarket Cap-17815P/E (TTM)
5.300High5.150Low3.40MVolume5.290Open5.260Pre Close17.77MTurnover0.23%Turnover RatioLossP/E (Static)1.76BShares7.49052wk High1.21P/B7.81BFloat Cap4.03052wk Low--Dividend TTM1.50BShs Float32.050Historical High--Dividend LFY2.85%Amplitude4.030Historical Low5.227Avg Price1000Lot Size--Div YieldTTM--Div Yield LFY
INNOCARE Stock Forum
This is a multicente...
In the...
Financial Highlights
• Revenue increased by 18.1% to RMB738.5 million in 2023, including RMB670.7 million from orelabrutinib, an increase of 18.5%, mainly due to the continuous and rapid ramp-up of orelabrutinib sales.
• Gross ...
No comment yet